phenylalanine has been researched along with ketanserin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, MS; Glennon, RA; Roth, BL; Sachs, N; Uluer, A; Westkaemper, RB | 1 |
| Choudhary, MS; Craigo, S; Roth, BL | 1 |
2 other study(ies) available for phenylalanine and ketanserin
| Article | Year |
|---|---|
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
Topics: Animals; Base Sequence; Binding Sites; Ergolines; Ergotamine; Ketanserin; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Point Mutation; Protein Binding; Receptors, Serotonin; Structure-Activity Relationship | 1995 |
A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
Topics: Amino Acid Sequence; Amphetamines; Animals; Base Sequence; Cell Line, Transformed; Chlorocebus aethiops; Ergolines; Hydrolysis; Ketanserin; Leucine; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Phosphatidylinositols; Point Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |